Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor Subtypes

Long-term effects of iloperidone on cerebral dopamine receptor subtypes

(2018) Yong Kee Choi et al.   SYNAPSE

GABAergic mechanisms of hippocampal hyperactivity in schizophrenia

(2015) Stephan Heckers et al.   SCHIZOPHRENIA RESEARCH

Role of α1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal symptoms

(2013) Stephen M. Stahl   CNS SPECTRUMS

Update on Typical and Atypical Antipsychotic Drugs

(2012) Herbert Y. Meltzer   Annual Review of Medicine

Iloperidone, asenapine and lurasidone: a primer on their current status

(2012) Frank I Tarazi et al.   EXPERT OPINION ON PHARMACOTHERAPY

Alpha-1 Adrenergic Receptors are Localized on Presynaptic Elements in the Nucleus Accumbens and Regulate Mesolimbic Dopamine Transmission

(2012) Darlene A Mitrano et al.   NEUROPSYCHOPHARMACOLOGY

Iloperidone: A new drug for the treatment of schizophrenia

(2011) S. A. Arif et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Signaling pathways in schizophrenia: emerging targets and therapeutic strategies

(2010) Caline S. Karam et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors

(2009) Yong Kee Choi et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Adjunctive α2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission

(2009) Monica M. Marcus et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Safety Profile of Iloperidone

(2008) Peter J. Weiden et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Asenapine induces differential regional effects on serotonin receptor subtypes

(2008) FI Tarazi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

(2008) M. Shahid et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET